Issue 7, 2016
From the journal:

MedChemComm

Retraction: Identifying the inhibitory mechanism of apigenin on the insulin ligand–receptor binding

Yong Yang*a  

* Corresponding authors

a Institute of Metabolic Disease Research and Drug Development, China Medical University, Shenyang, Liaoning 110001, People's Republic of China
E-mail: yyang@mail.cmu.edu.cn
Tel: +86 18900911994

Abstract

Retraction of ‘Identifying the inhibitory mechanism of apigenin on the insulin ligand–receptor binding’ by Yong Yang, Med. Chem. Commun., 2015, 6, 1190–1195.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C6MD90032A
Article type
Retraction
Submitted
20 Jun 2016
Accepted
20 Jun 2016
First published
27 Jun 2016
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2016,7, 1449-1449

Permissions

Request permissions

Retraction: Identifying the inhibitory mechanism of apigenin on the insulin ligand–receptor binding

Y. Yang, Med. Chem. Commun., 2016, 7, 1449 DOI: 10.1039/C6MD90032A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements